Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2014 (2014), Article ID 878670, 15 pages
http://dx.doi.org/10.1155/2014/878670
Review Article

Erectile Dysfunction in the Elderly: An Old Widespread Issue with Novel Treatment Perspectives

1Elderly Health Care, ASP Catanzaro, Via Spasari, 3, 88100 Catanzaro, Italy
2Geriatrician AUSL Modena, 41120 Modena, Italy
3Department of Medical Pathophysiology, “Sapienza” University of Rome, 00198 Rome, Italy
4Department of Science of Health, School of Medicine, University “Magna Græcia” of Catanzaro, 88100 Catanzaro, Italy
5Psychiatry Unit, “Mater Domini” University Hospital, 88100 Catanzaro, Italy

Received 17 November 2013; Revised 6 January 2014; Accepted 7 January 2014; Published 17 March 2014

Academic Editor: Antonio Aversa

Copyright © 2014 Pietro Gareri et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. J. Smith, J. P. Mulhall, S. Deveci, N. Monaghan, and M. C. Reid, “Sex after seventy: a pilot study of sexual function in older persons,” The Journal of Sexual Medicine, vol. 4, no. 5, pp. 1247–1253, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Bruzziches, D. Francomano, P. Gareri, A. Lenzi, and A. Aversa, “An update on pharmacological treatment of erectile dysfunction with phosphodiesterase type-5 inhibitors,” Expert Opinion on Pharmacotherapy, vol. 14, no. 10, pp. 1333–1344, 2013. View at Google Scholar
  3. T. F. Lue, “Erectile dysfunction,” The New England Journal of Medicine, vol. 342, no. 24, pp. 1802–1813, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Solomon, J. W. Man, and G. Jackson, “Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator,” Heart, vol. 89, no. 3, pp. 251–254, 2003. View at Google Scholar · View at Scopus
  5. S. T. Lindau, L. P. Schumm, E. O. Laumann, W. Levinson, C. A. O'Muircheartaigh, and L. J. Waite, “A study of sexuality and health among older adults in the United States,” England Journal of Medicine, vol. 357, no. 8, pp. 762–774, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. H. A. Feldman, I. Goldstein, D. G. Hatzichristou, R. J. Krane, and J. B. McKinlay, “Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study,” The Journal of Urology, vol. 151, no. 1, pp. 54–61, 1994. View at Google Scholar · View at Scopus
  7. G. Corona, D. M. Lee, G. Forti et al., “Age-related changes in general and sexual health in middle-aged and older men: results from the European Male Ageing Study (EMAS),” The Journal of Sexual Medicine, vol. 7, no. 4, pp. 1362–1380, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. C. A. Holden, R. I. McLachlan, M. Pitts et al., “Men in Australia Telephone Survey (MATeS): a national survey of the reproductive health and concerns of middle-aged and older Australian men,” The Lancet, vol. 366, no. 9481, pp. 218–224, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. S. T. Lindau, E. Abramsohn, K. Gosch et al., “Patterns and loss of sexual activity in the year following hospitalization for acute myocardial infarction (A U.S. National, Multi-Site Observational Study),” The American Journal of Cardiology, vol. 109, no. 10, pp. 1439–1444, 2012. View at Google Scholar
  10. R. Shiri, J. Koskimäki, J. Häkkinen et al., “Effects of age, comorbidity and lifestyle factors on erectile function: Tampere Ageing Male Urological Study (TAMUS),” European Urology, vol. 45, no. 5, pp. 628–633, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Aversa, R. Bruzziches, D. Francomano, M. Natali, P. Gareri, and G. Spera, “Endothelial dysfunction and erectile dysfunction in the aging man,” International Journal of Urology, vol. 17, no. 1, pp. 38–47, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. E. Chiurlia, R. D'Amico, C. Ratti, A. R. Granata, R. Romagnoli, and M. G. Modena, “Subclinical coronary artery atherosclerosis in patients with erectile dysfunction,” Journal of the American College of Cardiology, vol. 46, no. 8, pp. 1503–1506, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Gazzaruso, S. B. Solerte, A. Pujia et al., “Erectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with angiographically proven asymptomatic coronary artery disease: a potential protective role for statins and 5-phosphodiesterase inhibitors,” Journal of the American College of Cardiology, vol. 51, no. 21, pp. 2040–2044, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. I. M. Thompson, C. M. Tangen, P. J. Goodman, J. L. Probstfield, C. M. Moinpour, and C. A. Coltman, “Erectile dysfunction and subsequent cardiovascular disease,” Journal of the American Medical Association, vol. 294, no. 23, pp. 2996–3002, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Albersen, H. Orabi, and T. F. Lue, “Evaluation and treatment of erectile dysfunction in the aging male: a mini-review,” Gerontology, vol. 58, no. 1, pp. 3–14, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. A. I. El-Sakka and A. A. Yassin, “Review: amelioration of penile fibrosis: myth or reality,” Journal of Andrology, vol. 31, no. 4, pp. 324–335, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. X. L. Rudner, D. E. Berkowitz, J. V. Booth et al., “Subtype specific regulation of human vascular α1-adrenergic receptors by vessel bed and age,” Circulation, vol. 100, no. 23, pp. 2336–2343, 1999. View at Google Scholar · View at Scopus
  18. G. J. Christ, B. Stone, and A. Melman, “Age-dependent alterations in the efficacy of phenylephrine-induced contractions in vascular smooth muscle isolated from the corpus cavernosum of impotent men,” Canadian Journal of Physiology and Pharmacology, vol. 69, no. 7, pp. 909–913, 1991. View at Google Scholar · View at Scopus
  19. D. Browne, D. Meeking, K. Shaw, and M. Cummings, “Endothelial dysfunction and pre-symptomatic atherosclerosis in type 1 diabetes—pathogenesis and identification,” British Journal of Diabetes and Vascular Disease, vol. 3, no. 1, pp. 27–34, 2003. View at Google Scholar · View at Scopus
  20. P. M. Vanhoutte, “Ageing and endothelial dysfunction,” European Heart Journal Supplements, vol. 4, pp. A8–A17, 2002. View at Google Scholar
  21. B. Musicki, M. F. Kramer, R. E. Becker, A. L. Burnett, and I. S. de Tejada, “Age-related changes in phosphorylation of endothelial nitric oxide synthase in the rat penis,” The Journal of Sexual Medicine, vol. 2, no. 3, pp. 347–357, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. E. Wespes, “The ageing penis,” World Journal of Urology, vol. 20, no. 1, pp. 36–39, 2002. View at Google Scholar · View at Scopus
  23. M. G. Ferrini, H. H. Davila, E. G. A. Valente, N. F. Gonzalez-Cadavid, and J. Rajfer, “Aging-related induction of inducible nitric oxide synthase is vasculo-protective to the arterial media,” Cardiovascular Research, vol. 61, no. 4, pp. 796–805, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Traish and N. Kim, “The physiological role of androgens in penile erection: regulation of corpus cavernosum structure and function,” The Journal of Sexual Medicine, vol. 2, no. 6, pp. 759–770, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Hougaku, J. L. Fleg, S. S. Najjar et al., “Relationship between androgenic hormones and arterial stiffness, based on longitudinal hormone measurements,” American Journal of Physiology—Endocrinology and Metabolism, vol. 290, no. 2, pp. E234–E242, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. A. E. Hak, J. C. M. Witteman, F. H. de Jong, M. I. Geerlings, A. Hofman, and H. A. P. Pols, “Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam study,” The Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 8, pp. 3632–3639, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. G. A. Laughlin, E. Barrett-Connor, and J. Bergstrom, “Low serum testosterone and mortality in older men,” The Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 1, pp. 68–75, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. G. Corona, G. Rastrelli, E. Maseroli, G. Forti, and M. Maggi, “Sexual function of the ageing male,” Best Practice & Research: Clinical Endocrinology & Metabolism, vol. 27, no. 4, pp. 581–601, 2013. View at Publisher · View at Google Scholar
  29. J. K. Crews and R. A. Khalil, “Antagonistic effects of 17β-estradiol, progesterone, and testosterone on Ca2+ entry mechanisms of coronary vasoconstriction,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 19, no. 4, pp. 1034–1040, 1999. View at Google Scholar · View at Scopus
  30. J. B. Ruige, D. M. Ouwens, and J. M. Kaufman, “Beneficial and adverse effects of testosterone on the cardiovascular system in men,” The Journal of Clinical Endocrinology & Metabolism, vol. 98, no. 11, pp. 4300–4310, 2013. View at Google Scholar
  31. G. Corona, M. Gacci, E. Baldi, R. Mancina, G. Forti, and M. Maggi, “Androgen deprivation therapy in prostate cancer: focusing on sexual side effects,” The Journal of Sexual Medicine, vol. 9, no. 3, pp. 887–902, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. A. B. Araujo, J. M. Dixon, E. A. Suarez, M. H. Murad, L. T. Guey, and G. A. Wittert, “Endogenous testosterone and mortality in men: a systematic review and meta-analysis,” The Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 10, pp. 3007–3019, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. A. M. Isidori, J. Buvat, G. Corona et al., “A critical analysis of the role of testosterone in erectile function: from pathophysiology to treatment-a systematic review,” European Urology, vol. 65, no. 1, pp. 99–112, 2014. View at Google Scholar
  34. G. Corona, G. Rastrelli, A. Morelli, L. Vignozzi, E. Mannucci, and M. Maggi, “Hypogonadism and metabolic syndrome,” Journal of Endocrinological Investigation, vol. 34, no. 7, pp. 557–567, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. G. Corona, G. Rastrelli, and M. Maggi, “Diagnosis and treatment of late-onset hypogonadism: systematic review and meta-analysis of TRT outcomes,” Best Practice & Research: Clinical Endocrinology & Metabolism, vol. 27, no. 4, pp. 557–579, 2013. View at Google Scholar
  36. R. Vigen, C. I. O'Donnell, A. E. Barón et al., “Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels,” The Journal of the American Medical Association, vol. 310, no. 17, pp. 1829–1836, 2013. View at Publisher · View at Google Scholar
  37. S. Martin, E. Atlantis, D. Wilson et al., “Clinical and biopsychosocial determinants of sexual dysfunction in middle-aged and older Australian men,” The Journal of Sexual Medicine, vol. 9, no. 8, pp. 2093–2103, 2013. View at Publisher · View at Google Scholar
  38. C. Foresta, N. Caretta, G. Corona et al., “Clinical and metabolic evaluation of subjects with erectile dysfunction: a review with a proposal flowchart,” International Journal of Andrology, vol. 32, no. 3, pp. 198–211, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. B. D. Sachs, “The false organic-psychogenic distinction and related problems in the classification of erectile dysfunction,” International Journal of Impotence Research, vol. 15, no. 1, pp. 72–78, 2003. View at Publisher · View at Google Scholar · View at Scopus
  40. G. Corona, N. Mondaini, A. Ungar, E. Razzoli, A. Rossi, and F. Fusco, “Phosphodiesterase type 5 (PDE5) inhibitors in erectile dysfunction: the proper drug for the proper patient,” The Journal of Sexual Medicine, vol. 8, no. 12, pp. 3418–3432, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Vardi and A. Nini, “Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitus,” Cochrane Database of Systematic Reviews, no. 1, Article ID CD002187, 2007. View at Google Scholar · View at Scopus
  42. G. Corona, D. M. Lee, G. Forti et al., “Age-related changes in general and sexual health in middle-aged and older men: results from the European Male Ageing Study (EMAS),” The Journal of Sexual Medicine, vol. 7, no. 4, pp. 1362–1380, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. G. Corona, M. Monami, V. Boddi et al., “Male sexuality and cardiovascular risk. A cohort study in patients with erectile dysfunction,” The Journal of Sexual Medicine, vol. 7, no. 5, pp. 1918–1927, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. G. Corona, E. Mannucci, F. Lotti et al., “Pulse pressure, an index of arterial stiffness, is associated with androgen deficiency and impaired penile blood flow in men with ED,” The Journal of Sexual Medicine, vol. 6, no. 1, pp. 285–293, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. G. Jackson, R. C. Rosen, R. A. Kloner, and J. B. Kostis, “The second Princeton consensus on sexual dysfunction and cardiac risk: new guidelines for sexual medicine,” The Journal of Sexual Medicine, vol. 3, no. 1, pp. 28–36, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. I. Eardley, C. Donatucci, J. Corbin et al., “Pharmacotherapy for erectile dysfunction,” The Journal of Sexual Medicine, vol. 7, no. 1, pp. 524–540, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. J.-H. Jung, S.-C. Kam, S.-M. Choi, S.-U. Jae, S.-H. Lee, and J.-S. Hyun, “Sexual dysfunction in male stroke patients: correlation between brain lesions and sexual function,” Urology, vol. 71, no. 1, pp. 99–103, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. D. B. Celik, E. C. Poyraz, A. Bingöl, E. Idiman, S. Ozakbaş, and D. Kaya, “Sexual dysfunction ın multiple sclerosis: gender differences,” Journal of the Neurological Sciences, vol. 324, no. 1-2, pp. 17–20, 2013. View at Publisher · View at Google Scholar
  49. R. Sakakibara, M. Kishi, E. Ogawa et al., “Bladder, bowel, and sexual dysfunction in Parkinson’s disease,” Parkinson's Disease, vol. 2011, Article ID 924605, 21 pages, 2011. View at Publisher · View at Google Scholar
  50. P. Kotková and P. Weiss, “Psychiatric factors related to sexual functioning in patients with Parkinson's disease,” Clinical Neurology and Neurosurgery, vol. 115, no. 4, pp. 419–424, 2013. View at Google Scholar
  51. G. Bronner and D. B. Vodušek, “Management of sexual dysfunction in Parkinson's disease,” Therapeutic Advances in Neurological Disorders, vol. 4, no. 6, pp. 375–383, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. M. F. Mendez and J. S. Shapira, “Hypersexual behavior in frontotemporal dementia: a comparison with early-onset Alzheimer’s disease,” Archives of Sexual Behavior, vol. 42, no. 3, pp. 501–519, 2013. View at Google Scholar
  53. C. Y. Chen, C. P. Lee, Y. Chen, J. R. Jiang, C. L. Chu, and C. L. Chen, “The correlation between emotional distress and aging males' symptoms at a psychiatric outpatient clinic: sexual dysfunction as a distinguishing characteristic between andropause and anxiety/depression in aging men,” Clinical Interventions in Aging, vol. 8, pp. 635–640, 2013. View at Publisher · View at Google Scholar
  54. A. W. Pastuszak, N. Badhiwala, L. I. Lipshultz, and M. Khera, “Depression is correlated with the psychological and physical aspects of sexual dysfunction in men,” International Journal of Impotence Research, vol. 25, no. 5, pp. 194–199, 2013. View at Publisher · View at Google Scholar
  55. J.-Y. Jeong, S. K. Lee, Y.-W. Kang, S.-N. Jang, Y. J. Choi, and D.-H. Kim, “Relationship between ED and depression among middle-aged and elderly men in Korea: Hallym aging study,” International Journal of Impotence Research, vol. 23, no. 5, pp. 227–234, 2011. View at Publisher · View at Google Scholar · View at Scopus
  56. H. M. Tan, S. F. Tong, and C. C. K. Ho, “Men's health: sexual dysfunction, physical, and psychological health—is there a link?” The Journal of Sexual Medicine, vol. 9, no. 3, pp. 663–671, 2012. View at Publisher · View at Google Scholar · View at Scopus
  57. M. A. Perelman, “Erectile dysfunction and depression: screening and treatment,” Urologic Clinics of North America, vol. 38, no. 2, pp. 125–139, 2011. View at Publisher · View at Google Scholar · View at Scopus
  58. S. H. Kennedy, H. Dugré, and I. Defoy, “A multicenter, double-blind, placebo-controlled study of sildenafil citrate in Canadian men with erectile dysfunction and untreated symptoms of depression, in the absence of major depressive disorder,” International Clinical Psychopharmacology, vol. 26, no. 3, pp. 151–158, 2011. View at Publisher · View at Google Scholar · View at Scopus
  59. J. F. Kinzl, “Major depressive disorder, antidepressants and sexual dysfunction,” Neuropsychiatrie, vol. 23, no. 2, pp. 134–138, 2009. View at Google Scholar · View at Scopus
  60. A. K. Nagaraj, H. S. Nizamie, S. Akhtar, B. N. Sinha, and N. Goyal, “A comparative study of sexual dysfunction due to typical and atypical antipsychotics in remitted bipolar-I disorder,” Indian Journal of Psychiatry, vol. 46, no. 3, pp. 261–266, 2004. View at Google Scholar
  61. W. Hiller, W. Rief, and E. Brähler, “Somatization in the population: from mild bodily misperceptions to disabling symptoms,” Social Psychiatry and Psychiatric Epidemiology, vol. 41, no. 9, pp. 704–712, 2006. View at Publisher · View at Google Scholar · View at Scopus
  62. T. F. Lue and G. A. Broderick, “Evaluation and nonsurgical management of erectile dysfunction and premature ejaculation,” in Campbell-Walsh Urology, Elsevier, Amsterdam, The Netherlands, 9th edition, 2007. View at Google Scholar
  63. I. J. Korfage, S. Pluijm, M. Roobol, G. R. Dohle, F. H. Schröder, and M.-L. Essink-Bot, “Erectile dysfunction and mental health in a general population of older men,” The Journal of Sexual Medicine, vol. 6, no. 2, pp. 505–512, 2009. View at Publisher · View at Google Scholar · View at Scopus
  64. G. Corona, G. Rastrelli, M. Monami et al., “Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis,” European Journal of Endocrinology, vol. 168, no. 6, pp. 829–843, 2013. View at Publisher · View at Google Scholar
  65. B. P. Gupta, M. H. Murad, M. M. Clifton, L. Prokop, A. Nehra, and S. L. Kopecky, “The effect of lifestyle modification and cardiovascular risk factor reduction on erectile dysfunction: a systematic review and meta-analysis,” Archives of Internal Medicine, vol. 171, no. 20, pp. 1797–1803, 2011. View at Publisher · View at Google Scholar · View at Scopus
  66. E. A. Saltzman, A. T. Guay, and J. Jacobson, “Improvement in erectile function in men with organic erectile dysfunction by correction of elevated cholesterol levels: a clinical observation,” The Journal of Urology, vol. 172, no. 1, pp. 255–258, 2004. View at Google Scholar · View at Scopus
  67. A. L. Montejo-González, G. Llorca, J. A. Izquierdo et al., “SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients,” Journal of Sex and Marital Therapy, vol. 23, no. 3, pp. 176–194, 1997. View at Google Scholar · View at Scopus
  68. R. C. Rosen, R. M. Lane, and M. Menza, “Effects of SSRIs on sexual function: a critical review,” Journal of Clinical Psychopharmacology, vol. 19, no. 1, pp. 67–85, 1999. View at Publisher · View at Google Scholar · View at Scopus
  69. E. Wespes, E. Amar, D. Hatzichristou et al., “EAU guidelines on erectile dysfunction: an update,” European Urology, vol. 49, no. 5, pp. 806–815, 2006. View at Publisher · View at Google Scholar · View at Scopus
  70. M. Albersen, A. W. Shindel, K. B. Mwamukonda, and T. F. Lue, “The future is today: emerging drugs for the treatment of erectile dysfunction,” Expert Opinion on Emerging Drugs, vol. 15, no. 3, pp. 467–480, 2010. View at Publisher · View at Google Scholar · View at Scopus
  71. S. P. C. Sildenafil, “Sildenafil Summary of Product Characteristics,” http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000202/WC500049830.pdf.
  72. S. P. C. Vardenafil, “Vardenafil Summary of Product Characteristics,” http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000475/WC500039992.pdf.
  73. J. Jung, S. Choi, S. H. Cho et al., “Tolerability and pharmacokinetics of avanafil, a phosphodiesterase type 5 inhibitor: a single- and multiple-dose, double-blind, randomized, placebo-controlled, dose-escalation study in healthy Korean male volunteers,” Clinical Therapeutics, vol. 32, no. 6, pp. 1178–1187, 2010. View at Publisher · View at Google Scholar · View at Scopus
  74. M. Fujisawa and K. Sawada, “Clinical efficacy and safety of sildenafil in elderly patients with erectile dysfunction,” Archives of Andrology, vol. 50, no. 4, pp. 255–260, 2004. View at Publisher · View at Google Scholar · View at Scopus
  75. K. Hatzimouratidis and D. G. Hatzichristou, “A comparative review of the options for treatment of erectile dysfunction: which treatment for which patient?” Drugs, vol. 65, no. 12, pp. 1621–1650, 2005. View at Publisher · View at Google Scholar · View at Scopus
  76. A. J. Bella, L. X. Deyoung, M. Al-Numi, and G. B. Brock, “Daily administration of phosphodiesterase type 5 inhibitors for urological and nonurological indications,” European Urology, vol. 52, no. 4, pp. 990–1005, 2007. View at Publisher · View at Google Scholar · View at Scopus
  77. A. W. Shindel, “2009 update on phosphodiesterase type 5 inhibitor therapy part 1: recent studies on routine dosing for penile rehabilitation, lower urinary tract symptoms, and other indications (CME),” The Journal of Sexual Medicine, vol. 6, no. 7, pp. 1794–1808, 2009. View at Publisher · View at Google Scholar · View at Scopus
  78. A. Konstantinopoulos, K. Giannitsas, A. Athanasopoulos, D. Spathas, and P. Perimenis, “The impact of daily sildenafil on levels of soluble molecular markers of endothelial function in plasma in patients with erectile dysfunction,” Expert Opinion on Pharmacotherapy, vol. 10, no. 2, pp. 155–160, 2009. View at Publisher · View at Google Scholar · View at Scopus
  79. A. Müller, L. Smith, M. Parker, and J. P. Mulhall, “Analysis of the efficacy and safety of sildenafil citrate in the geriatric population,” BJU International, vol. 100, no. 1, pp. 117–121, 2007. View at Publisher · View at Google Scholar · View at Scopus
  80. R. Shabsigh, J. M. Kaufman, C. Steidle, and H. Padma-Nathan, “Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone,” The Journal of Urology, vol. 172, no. 2, pp. 658–663, 2004. View at Publisher · View at Google Scholar · View at Scopus
  81. A. Aversa, A. M. Isidori, G. Spera, A. Lenzi, and A. Fabbri, “Androgens improve cavernous vasodilation and response to sildenafil in patients with erectile dysfunction,” Clinical Endocrinology, vol. 58, no. 5, pp. 632–638, 2003. View at Publisher · View at Google Scholar · View at Scopus
  82. H. Sperling, F. Debruyne, A. Boermans, M. Beneke, E. Ulbrich, and S. Ewald, “The POTENT I randomized trial: efficacy and safety of an orodispersible vardenafil formulation for the treatment of erectile dysfunction,” The Journal of Sexual Medicine, vol. 7, no. 4, pp. 1497–1507, 2010. View at Publisher · View at Google Scholar · View at Scopus
  83. M. Sanford, “Vardenafil orodispersible tablet,” Drugs, vol. 72, no. 1, pp. 87–98, 2012. View at Publisher · View at Google Scholar · View at Scopus
  84. M. Gittelman, C. G. McMahon, J. A. Rodríguez-Rivera, M. Beneke, E. Ulbrich, and S. Ewald, “The POTENT II randomised trial: efficacy and safety of an orodispersible vardenafil formulation for the treatment of erectile dysfunction,” International Journal of Clinical Practice, vol. 64, no. 5, pp. 594–603, 2010. View at Publisher · View at Google Scholar · View at Scopus
  85. A. Salonia, A. Gallina, G. Zanni et al., “Acceptance of and discontinuation rate from erectile dysfunction oral treatment in patients following bilateral nerve-sparing radical prostatectomy,” European Urology, vol. 53, no. 3, pp. 564–570, 2008. View at Publisher · View at Google Scholar · View at Scopus
  86. R. Rosen, J. Altwein, P. Boyle et al., “Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7),” European Urology, vol. 44, no. 6, pp. 637–649, 2003. View at Publisher · View at Google Scholar · View at Scopus
  87. C. G. Roehrborn, “Lower urinary tract symptoms, benign prostatic hyperplasia, erectile dysfunction, and phosphodiesterase-5 inhibitors,” Reviews in Urology, vol. 6, no. 3, pp. 121–127, 2004. View at Google Scholar
  88. K.-E. Andersson, W. C. de Groat, K. T. McVary et al., “Tadalafil for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: pathophysiology and mechanism(s) of action,” Neurourology and Urodynamics, vol. 30, no. 3, pp. 292–301, 2011. View at Publisher · View at Google Scholar · View at Scopus
  89. M. Fujisawa and K. Sawada, “Clinical efficacy and safety of sildenafil in elderly patients with erectile dysfunction,” Archives of Andrology, vol. 50, no. 4, pp. 255–260, 2004. View at Publisher · View at Google Scholar · View at Scopus
  90. C. C. Carson III, “Cardiac safety in clinical trials of phosphodiesterase 5 inhibitors,” American Journal of Cardiology, vol. 96, no. 12, pp. 37M–41M, 2005. View at Publisher · View at Google Scholar · View at Scopus
  91. F. Giuliano, C. Donatucci, F. Montorsi et al., “Vardenafil is effective and well-tolerated for treating erectile dysfunction in a broad population of men, irrespective of age,” BJU International, vol. 95, no. 1, pp. 110–116, 2005. View at Publisher · View at Google Scholar · View at Scopus
  92. J. Borer and P. Armstrong, “Proceedings of the 99th meeting of the Food and Drug Administration Cardiovascular and Renal Drugs Advisory Committee. May 29th and 30th, 2003,” Circulation, vol. 107, no. 23, article e9052, 2003. View at Google Scholar · View at Scopus
  93. G. Corona, E. Razzoli, G. Forti, and M. Maggi, “The use of phosphodiesterase 5 inhibitors with concomitant medications,” Journal of Endocrinological Investigation, vol. 31, no. 9, pp. 799–808, 2008. View at Google Scholar · View at Scopus
  94. P. Gareri and G. de Sarro, “Principi di farmacologia geriatrica,” in Geriatria nel territorio. Un metodo per i vecchi, per i medici e per il futuro, S. Putignano, A. Cester, and P. Gareri, Eds., pp. 361–404, Critical Medicine Publishing s.r.l., Roma, Italy, 2012. View at Google Scholar
  95. T. Hedner, B. Edgar, L. Edvinsson, J. Hedner, B. Persson, and A. Pettersson, “Yohimbine pharmacokinetics and interaction with the sympathetic nervous system in normal volunteers,” European Journal of Clinical Pharmacology, vol. 43, no. 6, pp. 651–656, 1992. View at Publisher · View at Google Scholar · View at Scopus
  96. T. Lebret, J.-M. Hervé, P. Gorny, M. Worcel, and H. Botto, “Efficacy and safety of a novel combination of L-arginine glutamate and yohimbine hydrochloride: a new oral therapy for erectile dysfunction,” European Urology, vol. 41, no. 6, pp. 608–613, 2002. View at Publisher · View at Google Scholar · View at Scopus
  97. H. Ning, Z.-C. Xin, G. Lin, L. Banie, T. F. Lue, and C.-S. Lin, “Effects of icariin on phosphodiesterase-5 activity in vitro and cyclic guanosine monophosphate level in cavernous smooth muscle cells,” Urology, vol. 68, no. 6, pp. 1350–1354, 2006. View at Publisher · View at Google Scholar · View at Scopus
  98. H.-B. Xu and Z.-Q. Huang, “Icariin enhances endothelial nitric-oxide synthase expression on human endothelial cells in vitro,” Vascular Pharmacology, vol. 47, no. 1, pp. 18–24, 2007. View at Publisher · View at Google Scholar · View at Scopus
  99. Z.-B. Zhang and Q.-T. Yang, “The testosterone mimetic properties of icariin,” Asian Journal of Andrology, vol. 8, no. 5, pp. 601–605, 2006. View at Publisher · View at Google Scholar · View at Scopus
  100. W. J. G. Hellstrom, D. K. Montague, I. Moncada et al., “Implants, mechanical devices, and vascular surgery for erectile dysfunction,” The Journal of Sexual Medicine, vol. 7, no. 1, pp. 501–523, 2010. View at Publisher · View at Google Scholar · View at Scopus
  101. K. Hatzimouratidis, E. Amar, I. Eardley et al., “Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation,” European Urology, vol. 57, no. 5, pp. 804–814, 2010. View at Google Scholar · View at Scopus
  102. P. Tharyan and G. Gopalakrishanan, “Erectile dysfunction,” Clinical Evidence, vol. 15, pp. 1227–1251, 2006. View at Google Scholar · View at Scopus
  103. C. B. Harte and C. M. Meston, “Recreational use of erectile dysfunction medications in undergraduate men in the United States: characteristics and associated risk factors,” Archives of Sexual Behavior, vol. 40, no. 3, pp. 597–606, 2011. View at Publisher · View at Google Scholar · View at Scopus
  104. F. Korkes, A. Costa-matos, R. Gasperini, P. V. Reginato, and M. D. C. Perez, “Recreational use of PDE5 inhibitors by young healthy men: recognizing this issue among medical students,” The Journal of Sexual Medicine, vol. 5, no. 10, pp. 2414–2418, 2008. View at Publisher · View at Google Scholar · View at Scopus
  105. G. Schnetzler, I. Banks, M. Kirby, K. H. Zou, and T. Symonds, “Characteristics, behaviors, and attitudes of men bypassing the healthcare system when obtaining phosphodiesterase type 5 inhibitors,” The Journal of Sexual Medicine, vol. 7, no. 3, pp. 1237–1246, 2010. View at Publisher · View at Google Scholar · View at Scopus
  106. T. Melnik, “The psychological effects of recreational PDE5 inhibitor use,” Nature Reviews Urology, vol. 9, pp. 479–480, 2012. View at Google Scholar
  107. D. Puzzo, A. Staniszewski, S. XianDeng et al., “Phosphodiesterase 5 inhibition improves synaptic function, memory, and amyloid-β load in an Alzheimer's disease mouse model,” Journal of Neuroscience, vol. 29, no. 25, pp. 8075–8086, 2009. View at Publisher · View at Google Scholar · View at Scopus
  108. H. A. Ghofrani, I. H. Osterloh, and F. Grimminger, “Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond,” Nature Reviews Drug Discovery, vol. 5, no. 8, pp. 689–702, 2006. View at Publisher · View at Google Scholar · View at Scopus
  109. M. Albersen, E. Weyne, and T. J. Bivalacqua, “Stem cell therapy for erectile dysfunction: progress and future directions,” Sexual Medicine Reviews, vol. 1, no. 1, pp. 50–64, 2013. View at Publisher · View at Google Scholar